CDC/FDA: had no virus when they concocted the test for the virus | Eastern North Carolina Now

Article By Jon Rappoport on Jon Rappoport’s blog has the following.

"To confirm this, the CDC document links to an FDA release titled, “SARS-CoV-2 Reference Panel Comparative Data.” Here is a killer quote:

“During the early months of the Coronavirus Disease 2019 (COVID-19) pandemic, clinical specimens [of the virus] were not readily available to developers of IVDs [in vitro diagnostics] to detect SARS-CoV-2. Therefore, the FDA authorized IVDs based on available data from contrived samples generated from a range of SARS-CoV-2 material sources (for example, gene specific RNA, synthetic RNA, or whole genome viral RNA) for analytical and clinical performance evaluation. While validation using these contrived specimens provided a measure of confidence in test performance at the beginning of the pandemic, it is not feasible to precisely compare the performance of various tests that used contrived specimens because each test validated performance using samples derived from different gene specific, synthetic, or genomic nucleic acid sources.”